House stock trades/20030291-096
U.S. House PTR · Pennsylvania District 8

Rob Bresnahan

Sale · Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

April 8, 2025$1,001 - $15,000Document 20030291
Direct answer

What did this PTR report?

SALE

Rob Bresnahan reported a sale involving Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) (source ticker REGN) on April 8, 2025. The source reports $1,001 - $15,000.

Open official PDF page 11
Verified source fields

Transaction record

Filer
Rob Bresnahan
House district
PA08
Asset
Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
Official asset type
ST · Stocks (including ADRs)
Source ticker
REGN
Transaction code
S · Sale
Transaction date
April 8, 2025
Notification date
April 8, 2025
Reported value
$1,001 - $15,000
Owner field
Filer
Filing status
New
PDF location
Page 11 · row 8
Source context

Notes printed with this row

Subholding of
JP Morgan Brokerage Account
Interpretation boundary

A reported transaction is not a verdict.

THIS PAGE CAN SAY

The filer, asset text, codes, dates, amount label, filing status, and notes above appear in the fingerprinted official PTR at the cited page.

THIS PAGE CANNOT SAY

A disclosed transaction is not evidence of wrongdoing, material nonpublic information, intent, profit, loss, investment performance, a current holding, net worth, or a conflict of interest. Most dollar values are disclosure ranges, not exact transaction amounts. Some amended official rows contain an exact dollar value; amount_is_exact distinguishes those rows. Numeric bounds are derived only from an unambiguous source value and the original label is always retained.